European Journal of Pharmaceutics and Biopharmaceutics

Chemo-embolization of experimental liver metastases. Part I: distribution of biodegradable microspheres of different sizes in an animal model for the locoregional therapy
pp. 243-254(12)
Authors: Bastian P.; Bartkowski R.; Kohler H.; Kissel T.

Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats
pp. 255-263(9)
Authors: Roser M.; Fischer D.; Kissel T.

Codiffusion of propylene glycol and dimethyl isosorbide in hairless mouse skin
pp. 265-271(7)
Authors: Squillante E.; Needham T.; Maniar A.; Kislalioglu S.; Zia H.

Comparative investigations to evaluate the use of organotypic cultures of transformed and native dermal and epidermal cells for permeation studies
pp. 273-278(6)
Authors: Specht C.; Stoye I.; Muller-Goymann C.C.

In vitro percutaneous penetration through hairless rat skin: influence of temperature, vehicle and penetration enhancers
pp. 279-283(5)
Authors: Clarys P.; Alewaeters K.; Jadoul A.; Barel A.; Manadas R.O.; Preat V.

Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit
pp. 285-291(7)
Authors: Groning R.; Berntgen M.; Georgarakis M.

Hepatic kinetics of SCP-1 (N-[-(1,2-benzisothiazol-3(2H)-ona-1,1-dioxide-2-yl)-acetyl]-p-aminophenol ) compared with acetaminophen in isolated rat liver - II. Role of covalent binding in vivo
pp. 293-297(5)
Authors: Gonzalez-Martin G.; Lyndon C.; Sunkel C.

Altered pharmacokinetics of halofantrine by an antacid, magnesium carbonate
pp. 299-303(5)
Authors: Aideloje S.O.; Onyeji C.O.; Ugwu N.C.

Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin
pp. 305-311(7)
Authors: Frick A.; Moller H.; Wirbitzki E.

Biopharmaceutical characterization of oral controlled/modified-release drug products. In vitro/in vivo correlation of roxatidine
pp. 313-319(7)
Authors: Frick A.; Moller H.; Wirbitzki E.

Effect of ion exchange resins on the drug release from matrix tablets
pp. 321-327(7)
Authors: Sriwongjanya M.; Bodmeier R.

Polymorphism and desolvation of flupirtine maleate
pp. 329-337(9)
Authors: Landgraf K.-F.; Olbrich A.; Pauluhn S.; Emig P.; Kutscher B.; Stange H.

The effect of compression force on surface structure, crushing strength, friability and disintegration time of erythromycin acistrate tablets
pp. 339-345(7)
Authors: Riippi M.; Antikainen O.; Niskanen T.; Yliruusi J.

Evaluation of Vitacel M80K as a new direct compressible vehicle
pp. 347-353(7)
Authors: Nada A.H.; Graf E.

Characterization of an inclusion complex of cholesterol and hydroxypropyl--cyclodextrin
pp. 355-360(6)
Authors: Williams III R.O.; Mahaguna V.; Sriwongjanya M.

Increasing drug solubility by means of bile salt-phosphatidylcholine-based mixed micelles
pp. 361-367(7)
Authors: Hammad M.A.; Muller B.W.

Compaction of, and drug release from, coated drug pellets mixed with other pellets
pp. 369-379(11)
Authors: Lundqvist A.E.K.; Podczeck F.; Michael Newton J.

The tabletting machine as an analytical instrument: qualification of the measurement devices for punch forces and validation of the calibration procedures
pp. 381-395(15)
Authors: Belda P.M.; Mielck J.B.

Using three-, four-, and n-compartment closed models to estimate glomerular filtration rate during and after a constant rate intravenous infusion
pp. 397-402(6)
Author: Wu G.